Zenara Pharma gets CDSCO nod to manufacture Covid drug | India News
NEW DELHI: Zenara Pharma on Thursday said it has received the CDSCO approval to manufacture and sell combination packs of Nirmatrelvir and Ritonavirtablets, indicated as an option for patients with mild to moderate Covid-19 symptoms.!-->!-->!-->!-->!-->!-->…